Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
MedTech
Illumina gets go-ahead from EU to part ways with Grail
The DNA sequencing giant still has the freedom to choose between selling the cancer blood test developer outright or pursuing an independent spinout.
Conor Hale
Apr 12, 2024 10:11am
AI, DNA and drug testing tackles relapsed childhood cancers
Apr 11, 2024 6:00am
GE, Vanderbilt AI predicts cancer immunotherapy responses
Mar 5, 2024 1:04pm
Delfi debuts tumor-monitoring test alongside Immunocore collab
Feb 1, 2024 11:31am
Trialbee, Massive Bio link to match cancer patients with trials
Feb 1, 2024 10:00am
Agilent, Incyte ink hematology, oncology companion testing deal
Jan 30, 2024 12:28pm